Discovery could help to develop new drugs to treat organ transplant and cancer patients

(Medical Xpress) -- Loyola researchers are reporting surprising findings about a molecule that helps ramp up the immune system in some cases and suppress it in others.

The finding eventually could lead to to regulate the by, for example, revving it up to attack or tamping it down to prevent the of transplanted organs.

The study is published online ahead of print in the Journal of Immunology. Senior author is Makio Iwashima, PhD, an associate professor in the Department of Microbiology & Immunology of Loyola University Chicago Stritch School of Medicine. Co-authors are Robert Love, MD, a professor in the Departments of Thoracic & Cardiovascular Surgery and Microbiology & Immunology and one of the world's leading lung transplant surgeons, and first author Mariko Takami, PhD, of the Department of Microbiology & Immunology.

The immune system relies on a balancing act between two types of . Effector cells attack tumor cells and cells infected by viruses or bacteria. Regulatory cells suppress the immune system so that it does not attack healthy tissue. If effector cells are too active, an individual can suffer autoimmune disorders such as lupus, Type 1 diabetes and multiple sclerosis. But if regulatory cells are too active, the immune system will not be aggressive enough to protect the individual from germs and cancer.

The study involved an immune system molecule called transforming growth factor beta (TGF-ÿ). TGF-ÿ is known to be a powerful regulator of the immune response -- generally suppressing the strength of the response. In this study, however, Loyola researchers demonstrated that TGF-ÿ can amplify the immune response and result in a more effective targeted response under specific conditions.

"TGF-ÿ is a double-edged sword," Iwashima said. "It augments immune system reactions but does not determine what direction they will take. Depending on conditions, these reactions can either activate or suppress the immune system."

The study involved mouse cells grown ex vivo in laboratory dishes. The next steps will be to study TGF-ÿ in human cells and in animal models. Understanding the dual role of TGF-ÿ could help in the development of drugs to either activate or suppress the immune system, as needed, Iwashima said.

The study was supported by the National Institutes of Health and the Van Kampen Cardiovascular Research Fund.

add to favorites email to friend print save as pdf

Related Stories

Marijuana use suppresses immune functions, study shows

Dec 03, 2010

(PhysOrg.com) -- Smoking marijuana can trigger a suppression of the body’s immune functions, making cannabis users more susceptible to certain types of cancers and infections, according to a new study led by a University ...

Protection from the own immune system

Dec 01, 2008

Some 80,000 people in Germany suffer from multiple sclerosis – their immune system attacks and destroys healthy nerve tissue. Researchers at the Heidelberg University Hospital and the German Cancer Research Center in Heidelberg ...

Tumor wizardry wards off attacks from the immune system

Jul 14, 2006

Like the fictional wizard Harry Potter, some cancerous tumors seem capable of wrapping themselves in an invisibility cloak. Researchers at Washington University School of Medicine in St. Louis have found that pancreatic tumors ...

Study: Tumors inhibit immune system

May 29, 2006

Seattle scientists have shown that tumors can manipulate the immune system to stop it from attacking cancer cells, said a study published in Nature Immunology.

Recommended for you

Fresh hope for preventing pneumonia in the elderly

20 hours ago

There are calls for the frail and elderly not be be overlooked for vaccines against pneumonia this winter, with UNSW research challenging conventional wisdom on immunisation effectiveness in older patients.

Rural microbes could boost city dwellers' health

Apr 23, 2014

The greater prevalence of asthma, allergies and other chronic inflammatory disorders among people of lower socioeconomic status might be due in part to their reduced exposure to the microbes that thrive in rural environments, ...

User comments